Saturday, September 30, 2023


Rocket Pharmaceuticals Reaches FDA Alignment on Pivotal Phase 2 Trial Design for RP-A501 in Danon Disease

Rocket Pharmaceuticals, Inc, a leading late-stage biotechnology company advancing an integrated and sustainable pipeline of genetic therapies for rare disorders with high unmet need,...

Herophilus Announces Strategic Transaction with Genentech for Next-Generation Drug Discovery Platform

Herophilus, a leading biotechnology company with the mission to discover neurotherapeutics to cure complex brain diseases, announced that Genentech, a member of the Roche...

Neogen® Wins Best Innovative Luminol-Based Substrate Award

Neogen® Corporation announced that its K-Blue® Luminescent ONE has won the 2023 Best Innovative Luminol-Based Substrate award at the International Life Sciences Awards 2023. K-Blue...

Wolters Kluwer’s drug diversion solution receives outstanding rating in AI/ML effectiveness by KLAS

Newly acquired AI-based solution recognized for its success in combating drug diversion in healthcare facilities Wolters Kluwer Health is proud to announce that following its acquisition...

10x Genomics Surpasses 100 Xenium Analyzer Shipments

Rapid growth and adoption of Xenium Analyzer demonstrates strength of company's innovation engine, broad commercial reach and operational scale 10x Genomics, Inc., a leader in...

Hot Topics